Simron Singh

8.1k citations
168 papers · 5.9k · 4 hit papers · h-index 38

Impact in

Papers in

    • Neuroendocrine Tumor Research Advances 86
    • Multiple and Secondary Primary Cancers 2
    • COVID-19 and healthcare impacts 16
    • Global Cancer Incidence and Screening 2

Simron Singh

157 papers receiving 5.8k citations

Simron Singh's Hit Papers

Epidemiology of Neuroendocrine Neoplasms in the US 2025 · 33 citations
330+4+8Years since publication250500750

Peers

Simron Singh
Comparison fields: 5 of 78
  • Epidemiology 3.6k
  • Otorhinolaryngology 171
  • Oncology 460
  • Radiology, Nuclear Medicine and Imaging 146
  • Pulmonary and Respiratory Medicine 163
Replace Surendra Srinivas Shastri with:
Surendra Srinivas Shastri India
Carmen Martos Spain
Θεόδωρος Αγοραστός Greece
Ashish A. Deshmukh United States
Surbhi Grover United States
Aureli Torné Spain
Levi S. Downs United States
Marina T. van Leeuwen Australia
Carmel J. Cohen United States
Li C. Cheung United States
Simron Singh relative to Surendra Srinivas Shastri India Surendra Srinivas Shastri's profile →
Citations per field
00.5×2×3×4.4×
Surendra Srinivas Shastri · 1×
Citations per year

Countries citing papers authored by Simron Singh

Since Specialization
Citations

This map shows the geographic impact of Simron Singh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simron Singh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simron Singh more than expected).

Fields of papers citing papers by Simron Singh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Simron Singh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simron Singh. The network helps show where Simron Singh may publish in the future.

Co-authors

The 25 scholars most cited alongside Simron Singh, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Simron Singh Line = papers co-authored together Simron Singh links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 168 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Everolimus for the treatment of advanced, non-functional neuroendocrine tumours of the lung or gastrointestinal tract (RADIANT-4): a randomised, placebo-controlled, phase 3 study
Hit paper breakdown →
2015999
2
Exploring the rising incidence of neuroendocrine tumors: A population‐based analysis of epidemiology, metastatic presentation, and outcomes
Hit paper breakdown →
2014669
3 2017292
4
[177Lu]Lu-DOTA-TATE plus long-acting octreotide versus high‑dose long-acting octreotide for the treatment of newly diagnosed, advanced grade 2–3, well-differentiated, gastroenteropancreatic neuroendocrine tumours (NETTER-2): an open-label, randomised, phase 3 study
Hit paper breakdown →
2024214
5 2020144
6 2015136
7 2016125
8 2005116
9 202099
10 202089
11 202183
12 201781
13 201477
14 201475
15 201775
16 201873
17 201672
18 201768
19 202267
20 201864

About Simron Singh

Simron Singh is a scholar working on Epidemiology, Oncology, Otorhinolaryngology, Public Health, Environmental and Occupational Health and General Health Professions, having authored 168 papers that have together received 5.9k indexed citations. Recurring topics across this work include Neuroendocrine Tumor Research Advances (86 papers), COVID-19 and healthcare impacts (16 papers), Head and Neck Cancer Studies (5 papers), Telemedicine and Telehealth Implementation (4 papers), Palliative Care and End-of-Life Issues (4 papers), Gastric Cancer Management and Outcomes (3 papers), Global Cancer Incidence and Screening (2 papers) and Multiple and Secondary Primary Cancers (2 papers). The work is most often cited by research in Epidemiology (3.6k citations), Otorhinolaryngology (171 citations), Oncology (460 citations), Radiology, Nuclear Medicine and Imaging (146 citations) and Pulmonary and Respiratory Medicine (163 citations). Simron Singh has collaborated with scholars based in Canada, United States and Australia. Frequent co-authors include Calvin Law, Julie I. Hallet, Ning Liu, Refik Saskin, Moisés Cukier, David Lok Hang Chan, Eva Segelov, Jonathan Strosberg, Pamela L. Kunz and Matthew C. Cheung. Their work appears in journals such as Endocrine Related Cancer, Annals of Oncology, JAMA Network Open, Neuroendocrinology and JAMA Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact